Intraorbital lymphatic-venous malformation in an adult patient: is sirolimus the key?

Orbit. 2023 Jun 1:1-4. doi: 10.1080/01676830.2023.2214938. Online ahead of print.

Abstract

Intraorbital lymphatic-venous malformations are rare lesions that represent a therapeutic challenge given their location and high rate of recurrence, with only a few cases in adult patients having been published in the literature. We present the case of a 30-year-old male with a right intraorbital lymphatic-venous malformation treated with sirolimus at a dose of 4 mg/day with complete clinical and radiologic remission. Mild cold-like symptoms ensued during the first week of treatment and elevation of liver function enzymes and D-dimer occurred in the context of acute SARS-CoV-2 pneumonia. No major adverse effects were documented. After 18 months of treatment, the patient remains asymptomatic and ophthalmologic examinations including optical coherence tomography and visual field test are within normal values.

Keywords: Lymphatic-venous malformation; intraorbital; orbital apex; sirolimus.